EFFICIENT STEM CELL MOBILIZATION IN LENALIDOMIDE TREATED MULTIPLE MYELOMA PATIENTS CAN BE ACHIEVED BY MOBILIZATION WITH DCEP (DEXAMETHASONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATINUM) FOLLOWED BY HIGH-DOSE G-CSF

被引：0
|
作者：
Badin, S. M. [1 ]
Lendvai, N. [2 ]
Gounder, S. K. [1 ]
Rowley, S. [2 ]
Donato, M. [2 ]
Goldberg, S. [2 ]
Pecora, A. [2 ]
McBride, L. H. [2 ]
Schmidt, L. [2 ]
Donadio, K. A. [2 ]
McNeil, A. [2 ]
Siegel, D. S. [2 ]
机构：
[1] UMDNJ, Newark, NJ USA
[2] HUMC, Hackensack, NJ USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2008年 / 14卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2007.12.194
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
185
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [41] Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells
    Basak, Grzegorz W.
    Jaksic, Ozren
    Koristek, Zdenek
    Mikala, Gabor
    Basic-Kinda, Sandra
    Mayer, Jiri
    Masszi, Tamas
    Giebel, Sebastian
    Labar, Boris
    Wiktor-Jedrzejczak, Wieslaw
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (06) : 488 - 495
  • [42] Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies
    Awan, F.
    Kochuparambil, S. T.
    Falconer, D. E.
    Cumpston, A.
    Leadmon, S.
    Watkins, K.
    DeRemer, D.
    Jillella, A.
    Craig, M.
    Hamadani, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 (10) : 1279 - 1284
  • [43] Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies
    F Awan
    S T Kochuparambil
    D E Falconer
    A Cumpston
    S Leadmon
    K Watkins
    D DeRemer
    A Jillella
    M Craig
    M Hamadani
    Bone Marrow Transplantation, 2013, 48 : 1279 - 1284
  • [44] Low dose vs intermediate-high dose cyclophosphamide vs G-CSF stem cell mobilization in multiple myeloma in the era of novel agents: a multicenter study
    Saraceni, Francesco
    Pezzi, Annalisa
    Chiarucci, Martina
    Olivieri, Attilio
    Zuffa, Eliana
    Martino, Massimo
    Laszlo, Daniele
    Lanza, Francesco
    BONE MARROW TRANSPLANTATION, 2018, 53 : 777 - 778
  • [45] Initial experience of using G-CSF only for autologous stem cell mobilization in patients with multiple myeloma
    Putkonen, M. P.
    Remes, K. R.
    Kauppila, M. K.
    Salmenniemi, U. S.
    Itala-Remes, M. I-R
    BONE MARROW TRANSPLANTATION, 2013, 48 : S545 - S545
  • [46] Stem Cell Mobilization With Plerixafor plus G-CSF In Comparison To Cyclophosphamide plus G-CSF and Time-To-Progression After Autologous Stem Cell Transplantation For Multiple Myeloma
    Garfall, Alfred L.
    Dougherty, Andrew
    Vogl, Dan T.
    Weiss, Brendan M.
    Cohen, Adam D.
    Porter, David L.
    O'Doherty, Una
    Mangan, Patricia
    Cunningham, Kathleen
    Siegel, Don L.
    Stadtmauer, Edward A.
    BLOOD, 2013, 122 (21)
  • [47] Blood stem cell collections after mobilization with combination chemotherapy containing ifosfamide followed by G-CSF in multiple myeloma
    Straka, C
    Hebart, H
    Adler-Reichel, S
    Werding, N
    Emmerich, B
    Einsele, H
    ONCOLOGY, 2003, 65 : 94 - 98
  • [48] VINCRISTINE, CYCLOPHOSPHAMIDE, ADRYAMICIN AND DEXAMETHASONE (VCAD), WITH OR WITHOUT G-CSF, FOR MOBILIZATION OF CIRCULATING PROGENITOR CELLS IN PATIENTS WITH MULTIPLE-MYELOMA
    MAJOLINO, IVS
    MARCENO, R
    BUSCEMI, F
    INDOVINA, A
    SCIME, R
    LIBERTI, G
    PAMPINELLA, M
    GENTILE, S
    CARONIA, F
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1126 - 1126
  • [49] INTERMEDIATE-DOSE CYTARABINE plus G-CSF FOR STEM CELL MOBILIZATION IN PATIENTS WITH MULTIPLE MYELOMA REFERRED FOR DOUBLE AUTOHSCT
    Kruzel, T.
    Sadus-Wojciechowska, M.
    Najda, J.
    Czerw, T.
    Mendrek, W.
    Sobczyk-Kruszelnicka, M.
    Glowala-Kosinska, M.
    Chwieduk, A.
    Fidyk, W.
    Holowiecki, J.
    Giebel, S.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S526 - S526
  • [50] STEM CELL MOBILIZATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA FOLLOWING THERAPY WITH LENALIDOMIDE AND DEXAMETHASONE
    Kumar, S.
    Lacy, M. Q.
    Dispenzieri, A.
    Hayman, S. R.
    Dingli, D.
    Miceli, T.
    Litzow, M. R.
    Rajkumar, S. V.
    Gertz, M. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 66 - 66
12345